| Literature DB >> 32641108 |
C V Filippi1,2, J E Zubrzycki1,3, J A Di Rienzo4, F J Quiroz5, A F Puebla1, D Alvarez6, C A Maringolo5, A R Escande5, H E Hopp1,7, R A Heinz1,2,7, N B Paniego1,2, V V Lia8,9,10.
Abstract
BACKGROUND: Sclerotinia sclerotiorum is a necrotrophic fungus that causes Sclerotinia head rot (SHR) in sunflower, with epidemics leading to severe yield losses. In this work, we present an association mapping (AM) approach to investigate the genetic basis of natural resistance to SHR in cultivated sunflower, the fourth most widely grown oilseed crop in the world.Entities:
Keywords: Argentinian germplasm; Association mapping; Disease resistance; Sunflower
Mesh:
Year: 2020 PMID: 32641108 PMCID: PMC7346337 DOI: 10.1186/s12870-020-02529-7
Source DB: PubMed Journal: BMC Plant Biol ISSN: 1471-2229 Impact factor: 4.215
Candidate genes (CGs) for Sclerotinia Head Rot resistance analysed in this study. CGs successfully amplified in the AMP are underlined. a Acronyms used throughout this article. Gene target, chromosome, Gene start and Gene end refers to the genes annotated in Badouin et al. (2017), available at heliagene.org
| Source | Sunflower ID | Reference | Fold change | Sequencing primers | Gene target | Gene start (bp) | Gene End (bp) | Chromosome | |
|---|---|---|---|---|---|---|---|---|---|
| Sclerotinia differential expression assay ( | 2.36 | 0.01 | F: 5’AGCCCAGTGTCAAATCAACC3’ | AtRLP48 | 85,297,951 | 85,299,659 | HanXRQChr10 | ||
| R: 5′ TCCATACTTACGGTTCCACTCA 3′ | |||||||||
| 0.31 | 0.001 | F: 5’ATGCAAGCATGTGAAGCAGT 3′ | PLY2 | 39,465,262 | 39,466,985 | HanXRQChr17 | |||
| R: 5’CCCCAAGCAACATGACTTTT 3′ | |||||||||
| 2.95 | 0.001 | F: 5′ GGTGGACCATTTCATCAAGG 3′ | HanXRQChr14g0449241 | ######## | ######## | HanXRQChr14 | |||
| R: 5′ CGTGGGACAGCAACACTAAA 3′ | |||||||||
| −2.5 | 0.052 | F: 5′ CCACTCAATCTCCCCAAAAA 3′ | HSP41 | 12,595,842 | 12,596,417 | HanXRQChr06 | |||
| R: 5’CACCTTCGCCACTTTAATCC 3′ | |||||||||
| −2.78 | 0.001 | F: 5’CCGTCACCATTTTCACATTG3′ | HanXRQChr13g0415061 | ######## | ######## | HanXRQChr13 | |||
| R: 5’TAAATTTTGGGAACCGGACA3′ | |||||||||
| −3.7 | 0.055 | F: 5’CTCCGCAACCTCCACTACAT 3’ | HSP21 | 84,168,138 | 84,168,620 | HanXRQChr03 | |||
| R: 5’GAGGCAGCTTCTCCACAGTC 3’ | |||||||||
| 12.50 | 0 | F: 5′ CGTCTTCGTTGTTGCAATCT 3′ | HanXRQChr16g0506041 | 39,200,062 | 39,209,510 | HanXRQChr16 | |||
| R: 5’AGGAGGAGGATGAGGAGCAT 3′ | |||||||||
| −4.55 | 0 | F: 5’CAGGCCAAAGTCGAGAATGT 3′ | ASF2 | 39,035,731 | 39,038,365 | HanXRQChr16 | |||
| R: 5′ CACAAGGGAAACACAAACACTG 3′ | |||||||||
| Sclerotinia differential expression assay ( | 18.74 | 4.49E-5 | F: 5′ TGAAGGTCCATCTCCTCTTATTTC 3’ | HanXRQChr13g0395221 | 59,003,751 | 59,004,311 | HanXRQChr13 | ||
| R: 5′ GTCGCTAAAGCTCCGTTCAC 3′ | |||||||||
| 18.03 | 4.82E-6 | F: 5′ GGAACCTTATCCACCCGAAT 3′ | HanXRQChr06g0170521 | 17,800,642 | 17,804,614 | HanXRQChr06 | |||
| AT4G03400 | R: 5′ GCAAATCTTTCTCGGTGTCC 3′ | ||||||||
| 14.92 | 9.72E-6 | F: 5′ CTGATGAGTGGTCGGAGGTT 3′ | HanXRQChr10g0292811 | 95,584,317 | 95,586,370 | HanXRQChr10 | |||
| AT3G10190 | R: 5′ CCATCATTGTCGGCGTCTA 3′ | ||||||||
| 14.23 | 8.31E-7 | F: 5′ CAGGATAGTAGTCCCGATGGTG 3′ | HanXRQChr15g0463011 | 95,505 | 102,279 | HanXRQChr15 | |||
| R: 5′ TCAAAGGTTCCAGTCGCAAA 3′ | |||||||||
| 12.17 | 1.20E-7 | F: 5′ CCCGACACTTATTAAGACTCG 3′ | HanXRQChr13g0406751 | ######## | ######## | HanXRQChr13 | |||
| AT5G02140 | R: 5′ GCTGATCCTAGTCAACAACTGC 3′ | ||||||||
| 12.16 | 1.20E-5 | F: 5′ TTGCATTATCCTGATGTTATTATCTTG 3′ | HanXRQChr16g0509301 | 62,305,294 | 62,307,846 | HanXRQChr16 | |||
| AT3G19630 | R: 5′ TTGATGAATTATACCAACCTACCAAA 3′ | ||||||||
| 13.89 | 3.97E-7 | F: 5′ TAGGCGATCGATGCTCACTT 3′ | HanXRQChr14g0449241 | ######## | ######## | HanXRQChr14 | |||
| AT3G28390 | R: 5′ TCAAGGCGAGTAGGGTAAGC 3′ | ||||||||
| Sclerotinia head and stem rot association mapping ( | _ | _ | F: 5′ TCACATTCTCTTCATCCTATGCTC 3′ | HanXRQChr12g0360281 | 18,742,800 | 18,743,470 | HanXRQChr12 | ||
| R: 5′ CCAGTTCCACCAAGAACAGC 3′ | |||||||||
| _ | _ | F: 5′ TGCTTGTAACCTCCTCCTCCT 3′ | AB19A | ######## | ######## | HanXRQChr10 | |||
| R: 5′ TGTGGGAAAAGCATGATGTC 3′ | |||||||||
| _ | _ | F: 5′ TCAAGTGCTATGGCTACTAATGATTT 3′ | HanXRQChr06g0181801 | 74,845,978 | 74,847,869 | HanXRQChr06 | |||
| R: 5’TCGATGTATAAATGTATGGTAAAAGAA 3′ | |||||||||
| _ | _ | F: 5′ CCGATTTGCCACTGGATAAC 3’ | COI1 | ######## | ######## | HanXRQChr14 | |||
| R: 5′ ACACGCTGGATAGTCGTTCC 3’ | |||||||||
| _ | _ | F: 5′ TGCTATTGATGCTGGCAGTT 3′ | CYSEP | ######## | ######## | HanXRQChr09 | |||
| R: 5′ AATCATGTTTCACATACCAAATCTT 3′ | |||||||||
| _ | _ | F: 5′ CAAAGGAAGCAACAACACCA 3′ | HanXRQChr01g0029501 | ######## | ######## | HanXRQChr01 | |||
| R: 5′ TCGCTGATTCGATACCCTTT 3′ | |||||||||
| _ | _ | F: 5′ TGTGGTCTTCAAATTCATTAATAACC 3′ | PAL1 | 62,564,693 | 62,568,081 | HanXRQChr07 | |||
| R: 5′ GGCCATTCCTAACAGGATCA 3′ | |||||||||
| _ | _ | F: 5′ TTCTTTAGGCCAACCCTCAC 3’ | HanXRQChr16g0506311 | 40,982,842 | 40,983,492 | HanXRQChr16 | |||
| R: 5′ CCCTTAATCATAATTCACGAATGTC 3′ | |||||||||
| _ | _ | F: 5′ CCAAACCCGATGATGATAAA 3′ | HanXRQChr10g0289571 | 69,322,685 | 69,323,065 | HanXRQChr10 | |||
| R: 5′ AACAAACAAAACAAGCCACATT 3′ | |||||||||
| _ | _ | F: 5′ ACACCTCTCAACTTGCACCAAA 3′ | HanXRQChr17g0533851 | 2,017,423 | 2,019,342 | HanXRQChr17 | |||
| R: 5′ GCCCATGGATCTGAAGACAAA 3′ | |||||||||
| _ | _ | F: 5′ CAAGCCGCTAGAGATGGAAC 3′ | HanXRQChr16g0509771 | 66,374,292 | 66,377,376 | HanXRQChr16 | |||
| R: 5′ TCAACCCTGTGGTGTTTTGA 3′ | |||||||||
| _ | _ | F: 5′ TTGAGGGATTCTAATTGTTATAGTTGA3’ | ATROPGEF7 | 85,118,928 | 85,122,332 | HanXRQChr08 | |||
| R: 5′ TTCGGGTGTTCGTCCTTTT 3′ |
Fig. 1Box-plot of SHR-phenotypic variables in the three STRUCTURE clusters. a, DI: Disease incidence; b, AUDPCI: Area under the disease progress curve for disease incidence; c, DS: Disease severity; d, IP: Incubation period
Markers associated with SHR resistance (p ≤0.01; q-value < 0.20). Physical mapping of the associated markers, as well as Molecular Function and Gene Onthology (GO) assignment were retrieved from Heliagene.org, using the genome XRQ v1.0 (Badouin et al. 2017) [22]
| Marker | Chromosome | Position (bp) | Origin | Phenotypic variable | Molecular function | GOs |
|---|---|---|---|---|---|---|
| SNP117 | 10 | 132,349,611 | Illumina SNP-array | DI, AUDPCI, IP | 3-oxo-Delta(4,5)-steroid 5-beta-reductase | P:cellular metabolic process; F:coenzyme binding; F:catalytic activity |
| HaCOI_1 | 14 | 168,171,427 | CG (Talukder et al. 2014) [ | DS, AUDPCI, IP | insensitivity to coronatine | F: protein binding |
| HA1848 | 7 | – | SSR (Zubrzycki et al. 2017) [ | DS, DI, AUDPCI | – | – |
| SNP136 | 9 | 72,028,226 | Illumina SNP-array | DS, DI, AUDPCI | Beta-hexosaminidase 1 | P:carbohydrate metabolic process; C:cytoplasmic membrane-bounded vesicle; F:beta-N-acetylhexosaminidase activity; F:cation binding |
| SNP144 | 13 | 14,745,225 | Illumina SNP-array | DI, AUDPCI | Tyrosine transaminase family protein | F:pyridoxal phosphate binding; P:cellular amino acid and derivative metabolic process; F:1-aminocyclopropane-1-carboxylate synthase activity; P:vitamin E biosynthetic process; F:L-tyrosine:2-oxoglutarate aminotransferase activity |
| SNP128 | 12 | 18,758,084 | Illumina SNP-array | DI, AUDPCI | Germin-Like Protein 3 (HaGLP3) | F:superoxide dismutase activity; C:plant-type cell wall; F:oxalate oxidase activity; F:nutrient reservoir activity; P:oxidation reduction; P:auxin-mediated signaling pathway; F:oxidoreductase activity; |
| G33 | 16 | 62,306,954 | CG (Zhao et al. 2007) [ | DS | Radical SAM superfamily protein | F: catalytic activity; iron-sulfur cluster binding |
| SNP125 | 2 | 120,750,653 | Illumina SNP-array | DI | Xylulose kinase-2 | phosphate metabolic process;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;primary metabolic process;carbohydrate metabolic process |
| SNP80 | 14 | 170,322,057 | Illumina SNP-array | DI | Embryonic flower 2 | P:genetic imprinting; P:negative regulation of flower development; F:transcription factor activity; C:nucleus |
| SNP60 | 10 | 173,066,810 | Illumina SNP-array | DI | Serine-threonine/tyrosine-protein kinase | P: protein phosphorylation, F: Protein- serine/threonine kinase activity, F: ATP binding. |
| G34 | 14 | 137,657,256 | CG (Zhao et al. 2007) [ | DI | ATP-binding cassette, subfamily C, member 9 | P: potassium ion transport; F: ATP binding; sulfonylurea receptor activity; C: membrane |
| SNP23 | 15 | 16,332,782 | Illumina SNP-array | IP | Rho-associated protein kinase 1/2 | P:protein amino acid phosphorylation; F:ATP binding; F:protein serine/threonine kinase activity |
| SNP44 | 6 | 52,738,650 | Illumina SNP-array | DS | GRAS family transcription factor | P: positive regulation of transcription, DNA-templated regulation of transcription, DNA-templated, response to chitin, response to xenobiotic stimulus; F: DNA-binding transcription factor activity, sequence-specific DNA binding |
DI disease incidence, DS disease severity, AUDPCI area under the disease progress curve for disease incidence and IP incubation period
Performance of the inbred lines with the highest number of favourable alleles
| Inbred Line | SNP117 | HA1848 | SNP136 | SNP128 | SNP144 | SNP125 | SNP80 | G34 | SNP60 | HaCOI_1 | G33 | SNP44 | SNP23 | DI | AUDPCI | DS | IP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DI disease incidence, DS disease severity, AUDPCI area under the disease progress curve for disease incidence and IP incubation period